Found 10 matching trials
Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC NA The goal of this clinical trial is to evaluate the efficacy and safety of r...
Show More Location
Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer PHASE2 This randomized phase II exploratory clinical study aims to evaluate the ef...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer PHASE2 This study is a randomized, open-label, double-cohort, national multi-cente...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma PHASE2 This study aims to investigate the efficacy and safety of SHR-1701 in combi...
Show More Location
Multiple Locations
Learn More & Join Trial
An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging PHASE2 This study will evaluate whether two positron emission tomography/computed ...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer PHASE2 This study is a multicenter, randomized, two-cohort clinical trial to evalu...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer PHASE2 The goal of this clinical trial is to learn if SHR-1701 combine with chemor...
Show More Location
Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC PHASE2 Although phase III studies have confirmed the efficacy and safety of periop...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma PHASE2 This is a prospective, single-center, randomized controlled phase II clinic...
Show More Location
First Affiliated Hospital of Nanjing Medical Unviersity
Learn More & Join Trial
Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer PHASE2 This is a prospective, open-label, single-center, phase II umbrella trial d...
Show More Location
Multiple Locations
Learn More & Join Trial